(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SKIN X

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SKIN X

ST13

US500000087838002

Class

1, 5

Filing

87838002

Registration

5987245

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

02/18/2025

Trademark type

Word

Nice classes

1, 5

Filing date

03/16/2018

Registration date

02/18/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2020

Last transaction

02/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

64

Owner location

GÖTEBORG, SE

Examiner

BUTTON, JENNIFER

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CELLINK BIOPRINTING AB
Cellink AB

Representatives

Margarita Wallach, Esq. MCCARTER & ENGLISH, LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biologically compatible polymershydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medicalscientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrayshuman and animal organconnectiveepithelialmuscularnervous tissues and tissue arraysfor use in scientific and medical research; Biologically compatible materialshydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research

Class 5

Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Pharmaceutical preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organshuman and animal cardiovascularpulmonarydigestivehepatobiliaryurologicalrenalendocrineconnectiveepithelialmuscularnervous tissue and organsfor medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of boneblood and tissue for medical purposes; Pharmaceutical products for tissue regenerationfor tissue repairfor tissue treatmentwhether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseasesfor cartilaginous diseasesfor vascular diseasesfor neuronal degenerationfor degeneration of tendons and ligamentsfor retinal degenerationfor renal degenerationdegeneration of soft tissuefor diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy productsgenetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Natural biomaterials for augmentation of bone and tissue for medical purposes

Publications

History of USPTO decisions and trademark events.

38 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/18/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/15/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

01/14/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/14/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

11/26/2019

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

11/26/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/26/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/10/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/10/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/01/2019

PUBO

PUBLISHED FOR OPPOSITION

10/01/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/11/2019

ALIE

ASSIGNED TO LIE

08/28/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/27/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

08/27/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/27/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

08/27/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/27/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/09/2019

GNFR

FINAL REFUSAL E-MAILED

07/09/2019

CNFR

FINAL REFUSAL WRITTEN

07/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/09/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/08/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/08/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/03/2018

GNRT

NON-FINAL ACTION E-MAILED

12/03/2018

CNRT

NON-FINAL ACTION WRITTEN

12/03/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/31/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2018

ALIE

ASSIGNED TO LIE

10/24/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/15/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/14/2018

GNRT

NON-FINAL ACTION E-MAILED

04/14/2018

CNRT

NON-FINAL ACTION WRITTEN

04/14/2018

DOCK

ASSIGNED TO EXAMINER

04/06/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/23/2018

NWAP

NEW APPLICATION ENTERED

03/20/2018

Continuous trademark protection

Get notified about every new filing that threatens SKIN X or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.